Cravath Publishes Summer 2026 Issue of Alumni Journal
From the construction of the American railroads in the nineteenth century to the launch of global media companies in the twenty‑first, Cravath has been at the center of many of the world’s most important transactions. The hallmark of our corporate practice is our ability to bring together all of the Firm’s disciplines in an integrated and collaborative approach.
Cravath’s distinctive and rigorous system of training enables our lawyers to develop experience in a diverse range of areas, including mergers and acquisitions, capital markets, banking and credit, regulatory matters, corporate governance and board advisory, intellectual property and financial restructuring and reorganization. Our generalist training and internal cohesion allow us to draw upon a unique depth of corporate expertise in a highly efficient and effective way, delivering exceptional value to our clients.
Our counsel extends to helping companies, boards and executives navigate the opportunities and challenges presented by emerging technologies and trends in a global economy. This includes cybersecurity and data privacy, regulatory concerns, environmental, social and governance (“ESG”) considerations and other stakeholder engagement.
Our Corporate Department is a seven‑time winner of the Chambers USA Award for Excellence. Cravath has been recognized as a Law Firm of the Year by Law360 and the “Most Innovative Law Firm for Legal Expertise” by the Financial Times in its North America Innovative Lawyers report, which noted that the Firm “stood out for its persistence and ability to help define industries.” We have earned repeated praise from clients and the market:
Cravath’s distinctive and rigorous system of training enables our lawyers to develop experience in a diverse range of areas, including mergers and acquisitions, capital markets, banking and credit, regulatory matters, corporate governance and board advisory, intellectual property and financial restructuring and reorganization. Our generalist training and internal cohesion allow us to draw upon a unique depth of corporate expertise in a highly efficient and effective way, delivering exceptional value to our clients.
Our counsel extends to helping companies, boards and executives navigate the opportunities and challenges presented by emerging technologies and trends in a global economy. This includes cybersecurity and data privacy, regulatory concerns, environmental, social and governance (“ESG”) considerations and other stakeholder engagement.
Our Corporate Department is a seven‑time winner of the Chambers USA Award for Excellence. Cravath has been recognized as a Law Firm of the Year by Law360 and the “Most Innovative Law Firm for Legal Expertise” by the Financial Times in its North America Innovative Lawyers report, which noted that the Firm “stood out for its persistence and ability to help define industries.” We have earned repeated praise from clients and the market:
Deals & Cases
October 21, 2026
Cravath represented AerCap Funding Designated Activity Company in connection with its $1.5 billion registered senior notes offering. AerCap Funding Designated Activity Company is a wholly owned subsidiary of AerCap Holdings N.V., the global leader in aircraft leasing. The notes were listed on the Irish Stock Exchange. The transaction closed on October 7, 2026.
Deals & Cases
October 21, 2026
Cravath represented the underwriter in connection with the registered offering by an affiliate of Oaktree Capital Management, L.P. of $254 million of common shares of TORM plc., one of the world’s largest maritime transporters of refined oil products. The shares were listed on the Nasdaq. The transaction closed on October 7, 2026.
Deals & Cases
October 20, 2026
Cravath represented the agent and lenders in connection with the unitranche and revolving credit facilities made available to finance Apax Partners’ acquisition of Techoraco, a leading global events platform for the digital infrastructure market, and Institutional Investor, a leading global capital introduction and intelligence platform of curated, event-based memberships.
Deals & Cases
October 20, 2026
On October 20, 2026, Alcon, a global leader in eye care, announced it has acquired Neurotech Pharmaceuticals, Inc. (“Neurotech”), a company focused on developing innovative cell therapies for chronic and neurodegenerative eye diseases, for $550 million. Alcon may be required to make additional contingent payments, including upon the achievement of commercial milestones. This acquisition expands Alcon's retina portfolio with ENCELTO™, the first and only U.S. FDA-approved treatment for adults with idiopathic Macular Telangiectasia Type 2 (“MacTel”), a rare, progressive retinal disease that leads to irreversible central vision loss that has historically had no approved treatment options. Cravath represented Neurotech in connection with the transaction.
Deals & Cases
October 13, 2026
Cravath represented the underwriters in connection with the $800 million registered senior notes offering of Hoffman Schroff Holdings, Inc., an indirect wholly owned subsidiary of nVent Electric plc (“nVent”), a leading global provider of electrical connection and protection solutions. Net proceeds of the offering were used to finance nVent’s acquisition of Maverick Power, LLC. The transaction closed on September 29, 2026.
Activities
October 22, 2026
On October 20, 2026, Cravath and Stanford Law School co‑hosted a one‑day AI event at Stanford’s campus in Palo Alto, California. The day featured a program entitled “AI at an Inflection Point,” which examined the rapidly evolving global landscape for advanced AI, including the policy, national security, geopolitical and governance questions shaping its development and deployment. Cravath partner David J. Kappos delivered opening remarks and Cravath partner Ting S. Chen spoke in a fireside chat with Anthropic’s Chief Global Affairs Officer Tino Cuéllar. In addition, Cravath of counsel Scott B. Reents moderated a lunch conversation with authors Kevin Roose and Ethan Mollick in a session entitled “The Future and Business of AI,” which explored where AI is headed, what it means for work and society and how leaders should think about what comes next.
Activities
October 19, 2026
On October 19, 2026, Cravath partner David J. Kappos participated in Open Invention Network (“OIN”)’s inaugural OIN Connect 2026, which was held in San Jose, California. The event focused on how to stay innovative while minimizing IP risk in an era of exponential Open Source use. Dave delivered a keynote address entitled “IP World in a Time of Change – OIN’s Role in Sustained Long-term Patent Risk Mitigation.”
Activities
October 19, 2026
On October 16, 2026, Lawdragon announced the inclusion of 50 Cravath partners in its annual list of the “500 Leading Dealmakers in America.” The list, assembled based on research and vetting by peers, recognizes the lawyers in the areas of M&A, private equity, capital markets, finance, corporate governance, shareholder activism, tax, antitrust, regulatory, restructuring and energy who “close the transactions that remake industries, redraw markets and move trillions of dollars of value.”
Activities
October 15, 2026
On October 15, 2026, Cravath partner Ryan J. Wichtowski participated in the 7th Berkeley‑Tsinghua Transnational IP Conference, entitled “Transnational IP in an Age of AI and Global Competition” and hosted by the UC Berkeley Center for Law and Technology, the Berkeley Asia IP and Competition Law Center and Tsinghua University. The conference explored both the doctrinal challenges posed by advanced AI technologies and the practical realities facing innovative companies operating across jurisdictions. Ryan spoke on a panel entitled “IP Licensing and Commercialization: A U.S.‑China Comparative Perspective.”
Activities
October 07, 2026
On October 7, 2026, Cravath partner Tatiana Lapushchik participated in the American Bar Association’s NYC Commercial Finance Meeting. The event offered experts’ insights into the latest documentation trends of the U.S. corporate loan market and a deep dive into the negotiation of an intercreditor agreement in a bankruptcy context, as well as the ethics of negotiation. Tatiana spoke on a panel entitled “Loan Documentation: Market Trends and Selected Topics,” which examined “hostile” acquisition financings, spin‑off financings and digital infrastructure financings and compared documentation trends in broadly syndicated loans and private credit.
Deals & Cases
October 21, 2026
Cravath represented AerCap Funding Designated Activity Company in connection with its $1.5 billion registered senior notes offering. AerCap Funding Designated Activity Company is a wholly owned subsidiary of AerCap Holdings N.V., the global leader in aircraft leasing. The notes were listed on the Irish Stock Exchange. The transaction closed on October 7, 2026.
Deals & Cases
October 21, 2026
Cravath represented the underwriter in connection with the registered offering by an affiliate of Oaktree Capital Management, L.P. of $254 million of common shares of TORM plc., one of the world’s largest maritime transporters of refined oil products. The shares were listed on the Nasdaq. The transaction closed on October 7, 2026.
Deals & Cases
October 20, 2026
Cravath represented the agent and lenders in connection with the unitranche and revolving credit facilities made available to finance Apax Partners’ acquisition of Techoraco, a leading global events platform for the digital infrastructure market, and Institutional Investor, a leading global capital introduction and intelligence platform of curated, event-based memberships.
Deals & Cases
October 20, 2026
On October 20, 2026, Alcon, a global leader in eye care, announced it has acquired Neurotech Pharmaceuticals, Inc. (“Neurotech”), a company focused on developing innovative cell therapies for chronic and neurodegenerative eye diseases, for $550 million. Alcon may be required to make additional contingent payments, including upon the achievement of commercial milestones. This acquisition expands Alcon's retina portfolio with ENCELTO™, the first and only U.S. FDA-approved treatment for adults with idiopathic Macular Telangiectasia Type 2 (“MacTel”), a rare, progressive retinal disease that leads to irreversible central vision loss that has historically had no approved treatment options. Cravath represented Neurotech in connection with the transaction.
Deals & Cases
October 13, 2026
Cravath represented the underwriters in connection with the $800 million registered senior notes offering of Hoffman Schroff Holdings, Inc., an indirect wholly owned subsidiary of nVent Electric plc (“nVent”), a leading global provider of electrical connection and protection solutions. Net proceeds of the offering were used to finance nVent’s acquisition of Maverick Power, LLC. The transaction closed on September 29, 2026.
Activities
October 22, 2026
On October 20, 2026, Cravath and Stanford Law School co‑hosted a one‑day AI event at Stanford’s campus in Palo Alto, California. The day featured a program entitled “AI at an Inflection Point,” which examined the rapidly evolving global landscape for advanced AI, including the policy, national security, geopolitical and governance questions shaping its development and deployment. Cravath partner David J. Kappos delivered opening remarks and Cravath partner Ting S. Chen spoke in a fireside chat with Anthropic’s Chief Global Affairs Officer Tino Cuéllar. In addition, Cravath of counsel Scott B. Reents moderated a lunch conversation with authors Kevin Roose and Ethan Mollick in a session entitled “The Future and Business of AI,” which explored where AI is headed, what it means for work and society and how leaders should think about what comes next.
Activities
October 19, 2026
On October 19, 2026, Cravath partner David J. Kappos participated in Open Invention Network (“OIN”)’s inaugural OIN Connect 2026, which was held in San Jose, California. The event focused on how to stay innovative while minimizing IP risk in an era of exponential Open Source use. Dave delivered a keynote address entitled “IP World in a Time of Change – OIN’s Role in Sustained Long-term Patent Risk Mitigation.”
Activities
October 19, 2026
On October 16, 2026, Lawdragon announced the inclusion of 50 Cravath partners in its annual list of the “500 Leading Dealmakers in America.” The list, assembled based on research and vetting by peers, recognizes the lawyers in the areas of M&A, private equity, capital markets, finance, corporate governance, shareholder activism, tax, antitrust, regulatory, restructuring and energy who “close the transactions that remake industries, redraw markets and move trillions of dollars of value.”
Activities
October 15, 2026
On October 15, 2026, Cravath partner Ryan J. Wichtowski participated in the 7th Berkeley‑Tsinghua Transnational IP Conference, entitled “Transnational IP in an Age of AI and Global Competition” and hosted by the UC Berkeley Center for Law and Technology, the Berkeley Asia IP and Competition Law Center and Tsinghua University. The conference explored both the doctrinal challenges posed by advanced AI technologies and the practical realities facing innovative companies operating across jurisdictions. Ryan spoke on a panel entitled “IP Licensing and Commercialization: A U.S.‑China Comparative Perspective.”
Activities
October 07, 2026
On October 7, 2026, Cravath partner Tatiana Lapushchik participated in the American Bar Association’s NYC Commercial Finance Meeting. The event offered experts’ insights into the latest documentation trends of the U.S. corporate loan market and a deep dive into the negotiation of an intercreditor agreement in a bankruptcy context, as well as the ethics of negotiation. Tatiana spoke on a panel entitled “Loan Documentation: Market Trends and Selected Topics,” which examined “hostile” acquisition financings, spin‑off financings and digital infrastructure financings and compared documentation trends in broadly syndicated loans and private credit.
Explore
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.